Harmony Biosciences Holdings, Inc. (HRMY)
35.22
-0.26
(-0.73%)
USD |
NASDAQ |
Jun 11, 16:00
35.20
-0.02
(-0.06%)
After-Hours: 20:00
Harmony Biosciences Holdings SG&A Expense (Quarterly) : 64.20M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 64.20M |
| December 31, 2025 | 86.74M |
| September 30, 2025 | 59.36M |
| June 30, 2025 | 64.00M |
| March 31, 2025 | 61.95M |
| December 31, 2024 | 56.46M |
| September 30, 2024 | 56.16M |
| June 30, 2024 | 55.73M |
| March 31, 2024 | 52.91M |
| December 31, 2023 | 54.76M |
| September 30, 2023 | 45.96M |
| June 30, 2023 | 47.34M |
| March 31, 2023 | 44.63M |
| December 31, 2022 | 43.72M |
| September 30, 2022 | 41.80M |
| Date | Value |
|---|---|
| June 30, 2022 | 42.32M |
| March 31, 2022 | 35.46M |
| December 31, 2021 | 37.31M |
| September 30, 2021 | 33.34M |
| June 30, 2021 | 31.32M |
| March 31, 2021 | 30.05M |
| December 31, 2020 | 30.99M |
| September 30, 2020 | 23.11M |
| June 30, 2020 | 18.92M |
| March 31, 2020 | 22.54M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 14.27M |
| March 31, 2019 | 10.15M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 73.66M |
| Johnson & Johnson | 6.034B |
| Indivior Pharmaceuticals, Inc. | 124.00M |
| Royalty Pharma Plc | 159.49M |
| Corcept Therapeutics, Inc. | 145.36M |